Pharmaceutical
Who thinks outside the box to get more in it?
We do.
Our pharmaceutical team prides itself on advancing drug delivery with sophisticated science-based solutions. Our global centers of excellence contain the latest equipment and our research scientists and formulators are ready to work with you from concept to commercialization.
Now sold as Klucel™, Ashland introduced hydroxypropylcellulose (HPC) - an excipient that changed the drug delivery platform - to the market 65 years ago. And while others have followed, it was the solvers at Ashland who discovered it. Our full line of products combined with our global research and development capabilities can help deliver your drugs when and where they're needed resulting in better outcomes for patients and pharmaceutical companies alike.
With its significant history in pharmaceuticals and one of the widest available range of products for oral solid-dosage forms Ashland has a solid foundation to help find excipient and formulation solutions for you. Our global manufacturing sites, that operate in accordance with cGMP standards, provide consistently high quality products regardless of origin. As a full-service resource, Ashland can help you bind, coat, dissolve and deliver solutions that can yield better patient outcomes.
an overview of our pharmaceutical focus
|
Ashland solver and R&D Director of Pharmaceutical and Health & Wellness, Dr. Thomas Durig, discusses our latest innovations and solutions. |
read more >
related links
-
Oral Solid Dosage Form
Prescriptions for successful solutions
Read More >While an apple a day keeps the doctor away (and the teacher happy) there comes a time, in almost everyone's life, when medication - in tablet form - is needed. Our knowledge of the structure function of polymers, combined with our extensive product line can help you bind, coat, dissolve, and effectively deliver complex drug molecules where and when they're needed - making medication easier to swallow. And, easy to swallow medication often yields better patient compliance, which, in turn, yields better outcomes for everyone - a winning scenario. From concept to commericialization, working with Ashland makes medicine easy to swallow.
Ashland is unsurpassed in its ability to develop solutions for effective and efficient solutions to deliver today's complex drug molecules where and when they are needed. Our centers of excellence and manufacturing sites operate in accordance with cGMP standards. Our various chemistries and technologies are supported by a global team of research and development scientists. Ashland stands ready collaborate with you on new solutions to help take you from concept to commercialization. Our solutions include:
- Increasing the solubility of active pharmaceutical ingredients with low or no solubility
- Designing modified-release products to meet targeted release profiles
- Reducing tablet size while maintaining active pharmaceutical ingredient load
- Improving disintegration time of orally disintegrating tablets
- Understanding implications of continuous manufacturing technology for oral dosage production
Ongoing research provides a foundation for advanced technical solutions to address these and future formulation and manufacturing challenges. Ashland provides formulators with industry-changing technologies and unique opportunities for research and development collaboration.
-
Oral Liquid Dosage Form
Ashland helps the medicine go down
Read More >A spoonful of sugar may help the medicine go down, but the folks at Ashland, with their expertise in pharmaceutical formulations, know that there's more to it. Effective drug delivery in liquid form poses some unique challenges with rheology, texture, consistency and stability at the top of the list. Ashland's promise - always solving™ - inspires our goal of willing to work with you to find new sophisticated solutions to advance drug delivery. With our extensive polymer portfolio, R&D capabilities and testing facilities combined with your complex drug molecues, we can yield solutions that both deliver and improve the bioavailability of needed medication.
Targeted rheology, texture and stabilization in oral-liquid dosage forms play vital roles in delivery of the pharmaceutical components. The water binding and viscosity modification capacities of many of Ashland’s polymers thicken and suspend in liquids, gels, syrups and semi-solid dosage forms for improved patient satisfaction and shelf life of products. Contact us to learn more.
-
Other Dosage Form
Solutions that are more than skin deep
Read More >Our solutions are more than skin deep. Through transdermal and topical applications, skin can be an effective way to deliver some medications. Regardless of whether the drug is being delivered via gel, lotion, cream, ointment or foam, features including texture, adhesion, and spreadability, as well as feel and smell, are important attributes to consider for optimal patient compliance. For topical and transdermal application, Ashland's pharmacuetical team works with the talented skin care team to find alluring and luxurious ways to effectively and efficiently formulate topical and transdermal applications.
Topical treatments are administered to skin or mucous membranes to alleviate a variety of conditions. These treatments broadly encompass creams, foams, gels, lotions and ointments. There are a number of sought-after attributes for conferring desired properties to a topical formulation: rheology control, spreadability, adhesion and diffusion control. Ashland offers high-quality cellulose ethers such as Natrosol™ 250 hydroxyethylcellulose, Klucel™ hydroxypropylcellulose and Aqualon™ sodium carboxymethylcellulose to deliver these properties. Some of the topical film formers offered in our skin-care product lines are also suitable for use in topical applications. Plasdone™ povidone is also a good film former for topical applications. Contact us to learn more about our solutions for topical and transdermal applications.
-
EXCiPACT Certifications
EXCiPACT CertificationsWith six manufacturing facilities already certified by EXCiPACT, Ashland is well on its way to have all pharmaceutical excipient facilities certified by the end of 2017. Ashland continues its quest for high quality, which in turn, simplifies and streamlines your sourcing options.